Skye Bioscience (SKYE) Insider Trading & Ownership $3.48 +0.02 (+0.58%) Closing price 04:00 PM EasternExtended Trading$3.52 +0.04 (+1.29%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Skye Bioscience (NASDAQ:SKYE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$4.51M Get SKYE Insider Trade Alerts Want to know when executives and insiders are buying or selling Skye Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SKYE Insider Buying and Selling by Quarter Skye Bioscience Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/22/20255Am Partners Vii, LlcMajor ShareholderSell170,449$3.42$582,935.58 8/22/2025Andrew J SchwabDirectorSell170,449$3.42$582,935.58 8/21/20255Am Partners Vii, LlcMajor ShareholderSell60,956$3.57$217,612.92 8/21/2025Andrew J SchwabDirectorSell60,956$3.57$217,612.92 11/18/2024Kaitlyn ArsenaultCFOSell43,206$4.99$215,597.94 11/18/2024Paul A GraysonDirectorSell86,244$4.99$430,357.56 11/18/2024Punit DhillonCEOSell82,546$4.99$411,904.54 11/18/2024Tuan Tu DiepInsiderSell19,489$4.99$97,250.11 11/15/2024Kaitlyn ArsenaultCFOSell190$5.55$1,054.50 11/15/2024Paul A GraysonDirectorSell307$5.55$1,703.85 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/15/2024Punit DhillonCEOSell364$5.55$2,020.20 11/15/2024Tuan Tu DiepInsiderSell85$5.55$471.75 9/13/2024Andrew J SchwabDirectorSell13,837$6.06$83,852.22 9/11/2024Andrew J SchwabDirectorSell252,500$6.60$1,666,500.00 (Data available from 1/1/2013 forward) SKYE Insider Trading Activity - Frequently Asked Questions Who is on Skye Bioscience's Insider Roster? The list of insiders at Skye Bioscience includes 5Am Partners Vii, Llc, Andrew J Schwab, Kaitlyn Arsenault, Paul A Grayson, Punit Dhillon, and Tuan Tu Diep. Learn more on insiders at SKYE. What percentage of Skye Bioscience stock is owned by insiders? 4.50% of Skye Bioscience stock is owned by insiders. Learn more on SKYE's insider holdings. Which Skye Bioscience insiders have been selling company stock? The following insiders have sold SKYE shares in the last 24 months: 5Am Partners Vii, Llc ($800,548.50), Andrew J Schwab ($2,550,900.72), Kaitlyn Arsenault ($216,652.44), Paul A Grayson ($432,061.41), Punit Dhillon ($413,924.74), and Tuan Tu Diep ($97,721.86). How much insider selling is happening at Skye Bioscience? Insiders have sold a total of 961,578 Skye Bioscience shares in the last 24 months for a total of $4,511,809.67 sold. Skye Bioscience Key ExecutivesMr. Punit S. Dhillon B.A. (Age 44)Executive Chairman, President, CEO & Secretary Compensation: $720kDr. Christopher G. Twitty Ph.D. (Age 51)Chief Scientific Officer Mr. Tu Diep M.Sc. (Age 43)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Replimune Group Insider Transactions Esperion Therapeutics Insider Transactions CryoPort Insider Transactions Compass Therapeutics Insider Transactions Corvus Pharmaceuticals Insider Transactions Aura Biosciences Insider Transactions Olema Pharmaceuticals Insider Transactions Aquestive Therapeutics Insider Transactions Y-mAbs Therapeutics Insider Transactions Vigil Neuroscience Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:SKYE) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredSell this, buy thatI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access